Why the study?
Is the AGT M235T gene polymorphism associated with the risk of Henoch-Schönlein purpura (HSP) or Henoch-Schönlein purpura nephritis (HSPN)?
Is the AGT M235T gene polymorphism associated with the risk of Henoch-Schönlein purpura (HSP) or Henoch-Schönlein purpura nephritis (HSPN)?
The AGT M235T gene polymorphism may influence susceptibility to Henoch-Schönlein purpura in adults, with the M allele being protective and the TT genotype increasing risk.
May support AGT M235T testing for adult HSP risk; leaves open pediatric and HSPN roles pending prospective validation.
To evaluate the association between angiotensinogen (AGT) gene polymorphism and the risk of Henoch-Schönlein purpura (HSP)/Henoch-Schönlein purpura nephritis (HSPN) we searched the eligible studies through Pub Med, Embase, Cochrane, and China National Knowledge Infrastructure (CNKI) databases according to predefined criteria. A random-effects model was used to calculate the combined odds ratios (ORs) and its corresponding 95% confidence interval (CI). Five studies were recruited for the analysis of the association between AGT M235T gene polymorphism and HSP/HSPN risk. M allele was associated with lower risk of HSP in adult (p = 0.050), TT genotype was associated with the susceptibility to HSP in adult (p = 0.039). AGT M235T gene polymorphism was not associated with HSP risk in children. No marked association was observed between AGT M235T gene polymorphism and HSPN risk. No evidence of publication bias was observed. In conclusion, M allele might be a protective factor against the HSP risk in adult, TT genotype might be a risk factor for the susceptibility to HSP in adult. However, further larger studies should be performed in the future.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: